TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
SPS Pharma Solutions AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
425,701
|
407,559
|
347,468 |
| Financial expenses |
3,702
|
3,852
|
2,910 |
| Earnings before taxes |
-15,819
|
11,282
|
20,332 |
| EBITDA |
5,481
|
29,842
|
35,491 |
| Total assets |
427,874
|
365,505
|
331,357 |
| Current assets |
232,131
|
186,582
|
143,352 |
| Current liabilities |
145,964
|
129,459
|
68,547 |
| Equity capital |
270,121
|
220,953
|
165,500 |
| - share capital |
6,717
|
6,682
|
7,271 |
| Employees (average) |
322
|
312
|
278 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
63.1%
|
60.5%
|
49.9% |
| Turnover per employee |
1,322
|
1,306
|
1,250 |
| Profit as a percentage of turnover |
-3.7%
|
2.8%
|
5.9% |
| Return on assets (ROA) |
-2.8%
|
4.1%
|
7.0% |
| Current ratio |
159.0%
|
144.1%
|
209.1% |
| Return on equity (ROE) |
-5.9%
|
5.1%
|
12.3% |
| Change turnover |
16,044
|
88,236
|
27,224 |
| Change turnover % |
4%
|
28%
|
9% |
| Chg. No. of employees |
10
|
34
|
22 |
| Chg. No. of employees % |
3%
|
12%
|
9% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.